SCHEMBL23920171

SCHEMBL23920171

CC(C)(C)N/N=C(/c1ccc(-c2ccccc2)cc1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
GAA P10253 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
AGTR1 P30556 1/20 0.39
HTT P42858 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 2/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
WDR5 P61964 1/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24433675 0.89 GAA (0.47) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL23920015 0.80 SMN1; SMN2 (0.40) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL6546527 0.68 POLB (0.55) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL24409483 0.68 GAA (0.44) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL15820754 0.68 ALDH1A1 (0.47) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL8237871 0.66 SMN1; SMN2 (0.59) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL13246765 0.66 SMN1; SMN2 (0.59) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL10150704 0.66 SMN1; SMN2 (0.44) MAPTSMN1; SMN2GAAKDM4ERAB9A
SCHEMBL6416083 0.66 NPC1 (0.60) MAPTSMN1; SMN2GAAMEN1KMT2A
SCHEMBL22512523 0.65 GAA (0.48) MAPTGAAMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 US disclosed
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 MAPT 1310/4885SMN1; SMN2 4862/4885GAA 4334/4885
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 MAPT 1310/4885SMN1; SMN2 4862/4885GAA 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.